Bad Drugs Are Looking Good
Setup
Ketamine has sometimes been called the “date rape drug” because its sedative properties have enabled sexual assaults — but a groundbreaking study suggests it can also reduce symptoms of depression. Psychedelic drugs, such as psilocybin and LSD, can trigger a schizophrenic episode, but their potential to treat addiction, control post-traumatic stress disorder, and prepare terminally ill patients for death is intriguing. And while marijuana is a controlled substance under federal law, 33 states allow it to be sold for medical uses (and 11 say it’s okay for recreation). Researchers are taking a fresh look at the treatment value of drugs with a reputation for danger and making some surprising discoveries.
- 2019 Health
Is there such a thing as a bad drug?
Moderator John Torres, medical correspondent for NBC news, wants to know if the categorization of some drugs as “bad” drugs is warranted, and the panel responds unanimously:
Drugs are never inherently bad, explains Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies. It’s our relationship to drugs and the properties we choose to associate them with that can become problematic. These relationships are not fixed, says Doblin; they can evolve over time as science and society progress.
The science behind marijuana as a treatment for PTSD
Marijuana is is undergoing a complete reinvention from the days of Reefer Madness, and it’s already showing compelling results as a medicine. Mallory Loflin, research scientist at the Department of Veteran Affairs, is pioneering research into how cannabinoids — the specific compounds found in marijuana — could profoundly change how we treat PTSD.
How it works
Rick Doblin follows up Loflin's explanation with a reminder of the difficulties faced by researchers like Loflin in studying “bad” drugs, marijuana included. Because of their dubious reputations, regulatory quagmires often impede the ability of researchers to effectively study these drugs even in controlled environments.
Drugs are a tool, not a panacea
While it’s true that drugs like ketamine and MDMA have produced incredible results when used to treat some mental illnesses, Dennis Charney, dean of the Icahn School of Medicine, and Mallory Loflin want us to remember that they’re almost always used in conjunction with therapy and other treatments:
Claims about drugs can easily outpace research
Somewhat ironically, some “bad” drugs are shedding their notorious reputations and gaining reputations that drastically overstate their safe and effective usage. The panel explains, using examples from their own research, how this can quickly become problematic:
Learn More
Additional Information
Explore More
Economy
The United States spends $4.3 trillion—almost one fifth of the nation’s GDP—on health care. As the scale of the medical enterprise expands, venture capitalists are pursuing th...
In a time of growing wealth disparity and changing societal values, can capitalism adapt? How is the economy being transformed by investments in infrastructure, AI, energy, an...
In a time of growing wealth disparity and evolving societal values, can capitalism adapt to sustain the American Dream?
Women are twice as likely to invest in female-led businesses. Explore the ways women approach wealth building and investment, and how they create opportunities to build financ...
Join Jim Farley as he explores how drivers' needs and priorities are guiding the future of vehicle technology and reshaping our expectations of cars and trucks.
With ESG caught in the political culture wars, business executives must decide to speak up or stay quiet about climate, diversity and democracy. What do employees and citizens...
Africa is a rising giant. By 2050, one in four people on the planet will be African, and by 2060, Africa will have the largest labor force in the world. A former Nigerian pres...
Peter Thiel has made no secret of his feelings about economic and cultural issues. Hear him discuss his vision for the future, his bets on AI and digital currencies, his thoug...
Of the 1.2 billion youth aged 15 to 24 worldwide in 2019, close to half were out of school, out of work or underemployed, and this number will continue to grow. Listen as glob...
If you want to know where the economy is headed, ask an economist. If you want to know why (and more), ask a treasury secretary, an economic diplomat, a director of the Nation...
The market is at record highs. Unemployment is at record lows. And most economists will tell you the American economy is the envy of the world — but far too many working famil...
Poverty doesn’t care what color you are. Declining manufacturing jobs, income inequality and inadequate social safety nets affect all Americans. The problem of poverty demand...
With a staggering $84 trillion projected to change hands by 2045, the United States is on the brink of a historic intergenerational wealth exchange. How are our institutions p...
The U.S. is spending record amounts on infrastructure, with billions of federal dollars going to bridges, clean drinking water, broadband, and climate and energy. The governo...
In a recent op-ed, former U.S. climate envoy and secretary of state John Kerry declared that rich countries are failing to respond to the climate crisis. If extreme weather wi...
Niall Ferguson, the celebrated historian who predicted Cold War II in 2018, has assembled the sharpest minds from both sides of the Bamboo Curtain for a discussion on the futu...
Two legends — a baseball superstar and a Wall Street titan — discuss how they are leveraging their passion for professional sports as a team stakeholder and an owner.
Renewables are on the rise, but so is fossil fuel consumption as global development demands more and more. Does the oil and gas industry have a role in reaching net-zero goals...
Climate change is a threat multiplier with a disproportionate impact on vulnerable populations. Girls and women, who are denied equitable access to education and economic oppo...
